TY - JOUR
T1 - Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations
AU - Chiu, Yvonne E.
AU - Shmuylovich, Leonid
AU - Kiguradze, Tina
AU - Anderson, Katelyn
AU - Sibbald, Cathryn
AU - Tollefson, Megha
AU - Kunzler, Elaine
AU - Tom, Wynnis L.
AU - Bond, Kelsie
AU - Ahmad, Regina Celeste
AU - Garcia-Romero, Maria Teresa
AU - Irfan, Mahwish
AU - Kollman, Kaitlyn
AU - Hunt, Raegan
AU - Stein, Sarah L.
AU - Arkin, Lisa
AU - Wong, Vivian
AU - Pope, Elena
AU - Jacobe, Heidi
AU - Brandling-Bennett, Heather A.
AU - Cordoro, Kelly M.
AU - Bercovitch, Lionel
AU - Rangel, Stephanie M.
AU - Liu, Xuerong
AU - Szabo, Aniko
AU - Paller, Amy S.
N1 - Funding Information:
Funding sources: Supported by the Society for Pediatric Dermatology-Pediatric Dermatology Research Alliance, Dermatology Foundation .
Publisher Copyright:
© 2021 American Academy of Dermatology, Inc.
PY - 2021/7
Y1 - 2021/7
N2 - Background: The distribution of pediatric-onset morphea and site-based likelihood for extracutaneous complications has not been well characterized. Objective: To characterize the lesional distribution of pediatric-onset morphea and to determine the sites with the highest association of extracutaneous manifestations. Methods: A retrospective cross-sectional study was performed. Using clinical photographs, morphea lesions were mapped onto body diagrams using customized software. Results: A total of 823 patients with 2522 lesions were included. Lesions were more frequent on the superior (vs inferior) anterior aspect of the head and extensor (vs flexor) extremities. Linear morphea lesions were more likely on the head and neck, whereas plaque and generalized morphea lesions were more likely on the trunk. Musculoskeletal complications were more likely with lesions on the extensor (vs flexor) extremity (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.2-3.4), whereas neurologic manifestations were more likely with lesions on the anterior (vs posterior) (OR, 2.8; 95% CI, 1.7-4.6) and superior (vs inferior) aspect of the head (OR, 2.3; 95% CI, 1.6-3.4). Limitations: Retrospective nature and the inclusion of only patients with clinical photographs. Conclusion: The distribution of pediatric-onset morphea is not random and varies with body site and within individual body sites. The risk stratification of extracutaneous manifestations by body site may inform decisions about screening for extracutaneous manifestations, although prospective studies are needed.
AB - Background: The distribution of pediatric-onset morphea and site-based likelihood for extracutaneous complications has not been well characterized. Objective: To characterize the lesional distribution of pediatric-onset morphea and to determine the sites with the highest association of extracutaneous manifestations. Methods: A retrospective cross-sectional study was performed. Using clinical photographs, morphea lesions were mapped onto body diagrams using customized software. Results: A total of 823 patients with 2522 lesions were included. Lesions were more frequent on the superior (vs inferior) anterior aspect of the head and extensor (vs flexor) extremities. Linear morphea lesions were more likely on the head and neck, whereas plaque and generalized morphea lesions were more likely on the trunk. Musculoskeletal complications were more likely with lesions on the extensor (vs flexor) extremity (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.2-3.4), whereas neurologic manifestations were more likely with lesions on the anterior (vs posterior) (OR, 2.8; 95% CI, 1.7-4.6) and superior (vs inferior) aspect of the head (OR, 2.3; 95% CI, 1.6-3.4). Limitations: Retrospective nature and the inclusion of only patients with clinical photographs. Conclusion: The distribution of pediatric-onset morphea is not random and varies with body site and within individual body sites. The risk stratification of extracutaneous manifestations by body site may inform decisions about screening for extracutaneous manifestations, although prospective studies are needed.
KW - body area
KW - body site
KW - distribution
KW - location
KW - morphea
KW - scleroderma
UR - http://www.scopus.com/inward/record.url?scp=85103699225&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2021.03.017
DO - 10.1016/j.jaad.2021.03.017
M3 - Article
C2 - 33689776
AN - SCOPUS:85103699225
VL - 85
SP - 38
EP - 45
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
SN - 0190-9622
IS - 1
ER -